UnitedHealth Group Incorporated $UNH Stock Holdings Lessened by Longview Partners Guernsey LTD

Key Points

• Longview Partners Guernsey LTD has reduced its stake in UnitedHealth Group by 5.8%, owning 937,732 shares worth approximately $491 million.
• UnitedHealth Group's quarterly earnings report showed a miss on EPS estimates, with reported earnings of $4.08 compared to a consensus estimate of $4.45.
• The company will pay a quarterly dividend of $2.21 on September 23rd, with an annualized payout of $8.84 and a yield of 2.9%.

Longview Partners Guernsey LTD decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 937,732 shares of the healthcare conglomerate's stock after selling 58,130 shares during the period. UnitedHealth Group comprises 4.0% of Longview Partners Guernsey LTD's portfolio, making the stock its 14th largest holding. Longview Partners Guernsey LTD owned 0.10% of UnitedHealth Group worth $491,137,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter worth about $26,000. Bayforest Capital Ltd boosted its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new stake in UnitedHealth Group during the fourth quarter worth about $41,000. Finally, Copia Wealth Management purchased a new stake in UnitedHealth Group during the fourth quarter worth about $42,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Trading Up 1.2%

UNH stock traded up $3.51 on Wednesday, hitting $303.94. 9,956,016 shares of the company were exchanged, compared to its average volume of 21,825,404. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The business's fifty day moving average is $288.09 and its two-hundred day moving average is $384.83. The stock has a market capitalization of $275.27 billion, a price-to-earnings ratio of 13.17, a price-to-earnings-growth ratio of 1.94 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. HSBC restated a "reduce" rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. JPMorgan Chase & Co. cut their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday, August 6th. Mizuho cut their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $353.00.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.